Versant Ventures

Versant invests again in obesity, this time backing Helicore Biopharma
BioPharma Dive
Tue, 01/28/25 - 10:44 am
Versant Ventures
obesity
Helicore Biopharma
funding
Versant startup sets out to make a new type of obesity drug
BioPharma Dive
Thu, 11/21/24 - 11:13 am
Pep2Tango
Versant Ventures
obesity
drug development
Novartis, Versant hope to repeat Chinook’s success by arming kidney biotech Borealis with $150M
Fierce Biotech
Thu, 08/22/24 - 11:18 am
Novartis
Chinook Therapeutics
kidney disease
venture capital
Versant Ventures
Versant-founded biotech Nested hatches with $90M and new take on cancer drugs
MedCity News
Fri, 10/7/22 - 10:40 am
Nested Therapeutics
cancer
Versant Ventures
funding
Versant bets $30M on next-gen gene delivery startup Vector
Fierce Pharma
Mon, 08/15/22 - 10:12 am
Versant Ventures
gene delivery
venture capital
Vector BioPharma
New Versant Ventures startup goes ‘gutless’ for next-generation gene delivery
MedCity News
Wed, 08/10/22 - 10:36 am
Vector BioPharma
Versant Ventures
incubators
funding
Versant partners with AbCellera to arm startups with better antibodies
BioPharma Dive
Wed, 07/27/22 - 10:45 am
AbCellera
Versant Ventures
antibodies
drug development
Versant spinout lands $80M to go 'much broader' than the old Roche partnership that birthed it
Endpoints
Thu, 02/11/21 - 10:38 pm
Versant Ventures
Pipeline Therapeutics
Roche
Novartis bet $6B on the idea — now Versant, venBio have $45M to birth a platform play for radiopharmaceuticals
Endpoints
Wed, 10/14/20 - 10:51 am
Versant Ventures
PSMA-617
radiopharmaceuticals
prostate cancer
Novartis
Rayze Bio
venBio
Versant funds TCR therapy biotech T-knife's $78M+ Series A to boost humanized T cell mice platform
Endpoints
Thu, 08/6/20 - 10:12 am
Versant Ventures
venture capital
T-knife
A protein engineering platform spawns a new IL-2 player out of Basel, with human trials looming next summer
Endpoints
Tue, 07/28/20 - 11:06 am
protein engineering
Bright Peak Therapeutics
Versant Ventures
Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work
Xconomy
Thu, 08/8/19 - 12:57 pm
Bayer
Versant Ventures
cell therapy
M&A
BlueRock Therapeutics
Century Therapeutics Launches with $250 Million for Induced Pluripotent Stem Cell Platform
BioSpace
Tue, 07/2/19 - 10:22 am
Century Therapeutics
Versant Ventures
iPSC
solid tumors
Bayer powers Versant cell therapy startup to $250M round
Fierce Biotech
Mon, 07/1/19 - 10:21 am
Versant Ventures
Century Therapeutics
cell therapy
Bayer
venture capital
Versant Raises $100 Million to Develop Venture Ecosystem in Canadian Life Sciences Arena
Mon, 12/17/18 - 11:02 am
Versant Ventures
Canada
Versant partners gear up for a $700M bonanza of biotech bets, with a special focus all their own
Endpoints
Mon, 12/17/18 - 09:25 am
Versant Ventures
biotech
venture capital
Roche Acquires MS Remyelination Program from Versant Ventures
CP Wire
Wed, 04/4/18 - 08:52 am
Roche
MS
multiple sclerosis
remylination
M&A
Versant Ventures
Inception 5
Roche Acquires MS Remyelination Program from Versant Ventures
Wed, 04/4/18 - 08:50 am
Roche
Versant Ventures
multiple sclerosis
Biotech backer Versant arms itself with record $400M fund, targets a new wave of upstarts
Endpoints
Tue, 01/3/17 - 10:00 am
biotech
venture capital
Versant Ventures
Bayer, Versant close $225m Series A to launch stem cell company
Mass Device
Tue, 12/13/16 - 01:20 pm
Bayer
Versant Ventures
stem cells
Series A
BlueRock Therapeutics
devices
regenerative medicine

Pages